PA · ALERS.PA
Eurobio Scientific S.A.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Les Ulis 91953
- Website
- eurobioscientific.com
Price · as of 2024-12-31
$22.90
Market cap 234.59M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $74.26 | +224.28% |
| Intrinsic Value(DCF) | $10.14 | -55.72% |
| Graham-Dodd Method(GD) | $7.80 | -65.93% |
| Graham Formula(GF) | $10.12 | -55.82% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $48.60 | $127.83 | $6.50 | $0.00 | $0.00 |
| 2011 | $33.00 | $38.30 | $2.19 | $0.00 | $126.31 |
| 2012 | $19.20 | $138.21 | $6.97 | $0.00 | $0.00 |
| 2013 | $18.80 | $62.31 | $26,397.32 | $0.00 | $0.00 |
| 2014 | $12.40 | $155.43 | $2,191.51 | $0.00 | $0.00 |
| 2015 | $9.00 | $114.25 | $200.31 | $0.00 | $0.00 |
| 2016 | $5.20 | $21.55 | $0.00 | $0.00 | $0.00 |
| 2017 | $4.41 | $318.61 | $15.04 | $0.00 | $0.00 |
| 2018 | $3.15 | $202.48 | $45.77 | $0.00 | $0.00 |
| 2019 | $7.40 | $1,310.03 | $68.18 | $2.73 | $6.88 |
| 2020 | $19.55 | $219.09 | $13,074.16 | $40.47 | $1,418.00 |
| 2021 | $18.98 | $73.55 | $1,919.82 | $40.97 | $33.63 |
| 2022 | $18.00 | $92.06 | $218.37 | $17.72 | $0.00 |
| 2023 | $16.46 | $73.22 | $6.72 | $7.31 | $0.00 |
| 2024 | $25.35 | $74.26 | $0.92 | $7.80 | $10.12 |
AI valuation
Our deep-learning model estimates Eurobio Scientific S.A.'s (ALERS.PA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $74.26
- Current price
- $22.90
- AI upside
- +224.28%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$10.14
-55.72% upside
Graham-Dodd
$7.80
-65.93% upside
Graham Formula
$10.12
-55.82% upside
About Eurobio Scientific S.A.
Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
- CEO
- Denis Fortier
- Employees
- 329
- Beta
- 0.65
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($10.14 ÷ $22.90) − 1 = -55.72% (DCF, example).